JP2011517689A5 - - Google Patents

Download PDF

Info

Publication number
JP2011517689A5
JP2011517689A5 JP2011504377A JP2011504377A JP2011517689A5 JP 2011517689 A5 JP2011517689 A5 JP 2011517689A5 JP 2011504377 A JP2011504377 A JP 2011504377A JP 2011504377 A JP2011504377 A JP 2011504377A JP 2011517689 A5 JP2011517689 A5 JP 2011517689A5
Authority
JP
Japan
Prior art keywords
quinolin
yloxy
phenyl
fluoro
dimethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011504377A
Other languages
English (en)
Japanese (ja)
Other versions
JP5746015B2 (ja
JP2011517689A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/002798 external-priority patent/WO2009127417A1/en
Publication of JP2011517689A publication Critical patent/JP2011517689A/ja
Publication of JP2011517689A5 publication Critical patent/JP2011517689A5/ja
Application granted granted Critical
Publication of JP5746015B2 publication Critical patent/JP5746015B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011504377A 2008-04-16 2009-04-16 Axlキナーゼ阻害剤としてのキノリン誘導体 Active JP5746015B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4539808P 2008-04-16 2008-04-16
US61/045,398 2008-04-16
PCT/EP2009/002798 WO2009127417A1 (en) 2008-04-16 2009-04-16 Quinoline derivatives as axl kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2011517689A JP2011517689A (ja) 2011-06-16
JP2011517689A5 true JP2011517689A5 (https=) 2012-05-31
JP5746015B2 JP5746015B2 (ja) 2015-07-08

Family

ID=40999731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011504377A Active JP5746015B2 (ja) 2008-04-16 2009-04-16 Axlキナーゼ阻害剤としてのキノリン誘導体

Country Status (12)

Country Link
US (1) US9206130B2 (https=)
EP (1) EP2262772B8 (https=)
JP (1) JP5746015B2 (https=)
KR (1) KR101325237B1 (https=)
CN (1) CN102131783A (https=)
AU (1) AU2009237938A1 (https=)
CA (1) CA2718538A1 (https=)
ES (1) ES2391373T3 (https=)
IL (1) IL208103A (https=)
MX (1) MX2010011224A (https=)
RU (1) RU2010146474A (https=)
WO (1) WO2009127417A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311809A1 (en) * 2009-10-16 2011-04-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Quinolinyloxyphenylsulfonamides
EP2423208A1 (en) * 2010-08-28 2012-02-29 Lead Discovery Center GmbH Pharmaceutically active compounds as Axl inhibitors
ITRM20100537A1 (it) 2010-10-12 2012-04-12 Consiglio Nazionale Ricerche Aptamero inibitore del recettore tirosina chinasi axl per uso in terapia
SG11201402004YA (en) * 2011-11-14 2014-05-29 Cephalon Inc Uracil derivatives as axl and c-met kinase inhibitors
DK2810937T3 (en) 2012-01-31 2017-03-13 Daiichi Sankyo Co Ltd PYRIDONE DERIVATIVES
EP3184121A3 (en) 2012-07-25 2017-09-27 Salk Institute For Biological Studies Lipid membranes with exposed phosphatidylserine as tam ligands, use for treating autoimmune diseases
TWI649308B (zh) 2013-07-24 2019-02-01 小野藥品工業股份有限公司 喹啉衍生物
AU2014353006B2 (en) 2013-11-20 2019-04-04 Signalchem Life Sciences Corp. Quinazoline derivatives as TAM family kinase inhibitors
WO2015077550A1 (en) * 2013-11-22 2015-05-28 University Of Kentucky Research Foundation Arylquinoline and analog compounds and use thereof to treat cancer
US10233176B2 (en) 2013-11-27 2019-03-19 Signalchem Lifesciences Corporation Aminopyridine derivatives as TAM family kinase inhibitors
TWI723572B (zh) 2014-07-07 2021-04-01 日商第一三共股份有限公司 具有四氫吡喃基甲基之吡啶酮衍生物及其用途
ES2749726T3 (es) * 2014-12-25 2020-03-23 Ono Pharmaceutical Co Derivado de quinolina
US9840503B2 (en) 2015-05-11 2017-12-12 Incyte Corporation Heterocyclic compounds and uses thereof
US9708333B2 (en) 2015-08-12 2017-07-18 Incyte Corporation Fused bicyclic 1,2,4-triazine compounds as TAM inhibitors
WO2017035366A1 (en) 2015-08-26 2017-03-02 Incyte Corporation Pyrrolopyrimidine derivatives as tam inhibitors
WO2017146236A1 (ja) 2016-02-26 2017-08-31 小野薬品工業株式会社 Axl阻害剤と免疫チェックポイント阻害剤とを組み合わせて投与することを特徴とする癌治療のための医薬
KR102483020B1 (ko) 2016-03-28 2023-01-04 인사이트 코포레이션 Tam 저해제로서의 피롤로트리아진 화합물
CN108250200A (zh) * 2016-12-28 2018-07-06 中国科学院上海药物研究所 一种具有Axl抑制活性的化合物及其制备和应用
TWI779007B (zh) 2017-01-26 2022-10-01 日商小野藥品工業股份有限公司 喹啉衍生物的乙磺酸鹽
US20200197385A1 (en) 2017-08-23 2020-06-25 Ono Pharmaceutical Co., Ltd. Therapeutic agent for cancer containing axl inhibitor as active ingredient
TW201920104A (zh) * 2017-08-31 2019-06-01 美商馬愈法瑪公司 外核苷酸焦磷酸酶-磷酸二酯酶1(enpp-1)抑制劑及其用途
MA50655B1 (fr) 2017-09-27 2021-11-30 Incyte Corp Sels de dérivés de pyrrolotriazine utiles en tant qu'inhibiteurs de tam
US11826363B2 (en) 2017-10-13 2023-11-28 Ono Pharmaceutical Co., Ltd. Therapeutic agent for solid cancers, which comprises Axl inhibitor as active ingredient
AR117600A1 (es) 2018-06-29 2021-08-18 Incyte Corp Formulaciones de un inhibidor de axl / mer
EA202192575A1 (ru) 2019-03-21 2022-01-14 Онксео Соединения dbait в сочетании с ингибиторами киназ для лечения рака
CN114761006A (zh) 2019-11-08 2022-07-15 Inserm(法国国家健康医学研究院) 对激酶抑制剂产生耐药性的癌症的治疗方法
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
WO2021178779A1 (en) 2020-03-06 2021-09-10 Incyte Corporation Combination therapy comprising axl/mer and pd-1/pd-l1 inhibitors
JP2023525757A (ja) * 2020-05-08 2023-06-19 ジョージアミューン・インコーポレイテッド Akt3モジュレーター
JP2022104746A (ja) * 2020-12-29 2022-07-11 国立研究開発法人国立がん研究センター 抗がん剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9510757D0 (en) * 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
ATE356117T1 (de) * 1999-01-22 2007-03-15 Kirin Brewery Derivate des n-((chinolinyl)oxy)-phenyl)- harnstoffs und des n-((chinazolinyl)oxy)-phenyl)- harnstoffs mit antitumor aktivität
US7041691B1 (en) * 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
EP1566379A4 (en) * 2002-10-29 2005-11-09 Kirin Brewery CHINOLINE DERIVATIVES AND CHINAZOLINE DERIVATIVES AS INHIBITORS OF FLT3 AUTOPHOSPHORYLATION AND THE MEDICAL COMPOSITIONS CONTAINING THEREOF
EP2210607B1 (en) * 2003-09-26 2011-08-17 Exelixis Inc. N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer
GB0509227D0 (en) 2005-05-05 2005-06-15 Chroma Therapeutics Ltd Intracellular enzyme inhibitors
CA2619037A1 (en) * 2005-08-22 2007-03-01 Boehringer Ingelheim International Gmbh Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof
JP2009539878A (ja) * 2006-06-08 2009-11-19 アレイ バイオファーマ、インコーポレイテッド キノリン化合物および使用方法
PL2101759T3 (pl) * 2006-12-14 2019-05-31 Exelixis Inc Sposoby stosowania inhibitorów MEK

Similar Documents

Publication Publication Date Title
JP2011517689A5 (https=)
RU2010146474A (ru) Производные хинолина в качестве ингибиторов axl киназ
US12234221B2 (en) Pyridine carboxamide compounds for inhibiting NAV1.8
US11993581B2 (en) Pyridazine compounds for inhibiting Nav1.8
JP2013525293A5 (https=)
JP4731114B2 (ja) 置換スルホンアミド化合物、cns障害、肥満およびii型糖尿病の処置のための医薬としてのそれらの使用方法
AU2017253937B2 (en) Compounds and compositions for treating conditions associated with NLRP activity
CN101094829B (zh) 新的氨茴酸衍生物或其盐
JP2005526056A (ja) フタルイミドカルボン酸誘導体
RU2576036C2 (ru) Модуляторы активности нес1 и способы для них
ES2297382T3 (es) Derivados de sulfonamida como moduladores de ppar.
WO2008048991A2 (en) Organic compounds
RU2008112184A (ru) Производное тиазола
CA2757761A1 (en) Sulfamoyl benzoic acid derivatives as trpm8 antagonists
AU2007282465C1 (en) Sulfonamide compound or salt thereof
US20070276011A1 (en) Plasminogen Activator Inhibitor-1 Inhibitor
JP2008545686A5 (https=)
RU2007100229A (ru) Производные сульфонамида
RU2460723C2 (ru) Производные 4-(1-аминоэтил)циклогексиламина
RU2006116421A (ru) Анилиды салициловой кислоты
RU2013120137A (ru) Производные тетрагидрохинолина в качестве активаторов амрк
CA2628875A1 (en) Diaryl ureas for treating diabetic neuropathy
RU2017115036A (ru) Производные бензилгидроксида, их получение и их терапевтическое применение
MXPA06006211A (en) Biaryl sulfonamides as mmp inhibitors